21.69 USD
↘ 0.48 (2.17%)PRE MARKET (AS OF 08:32 AM EDT)
GH Research PLC Ordinary Shares
GHRSNASDAQ • USD
Market: OPEN
GH Research PLC Ordinary Shares (GHRS) trades at $21.69 per share. Technical indicators currently signal "Sell". This is driven by a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Oct 5, 2026.
Open?$22.63
High?$23.19
Low?$21.69
Prev. Close?$22.17
Volume?439
Avg. Volume?N/A
VWAP?$23.02
Bid / Ask
Bid?$18.01 × 100
Ask?$27.51 × 100
Spread?$9.50
Midpoint?$22.76
Valuation & Ratios
Market Cap?1.5B
Shares Out?68.6M
Float?44.1M
Float %?64.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?6.13%Elevated
Short Interest?2.7M
Days to Cover?14.3
Free Float44.1M
Avg Daily Volume189.4K
Settlement Date2026-09-15